icon
موقع حكومي رسمي تابع لحكومة المملكة العربية السعودية
icon الخميس 11 جمادى الأولى 1448هـ
نسخة تجريبية
icon
روابط المواقع الالكترونية الرسمية السعودية تنتهي بـ gov.sa

جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa

icon
المواقع الرسمية الآمنة تستخدم HTTPS

تحقق من أن الموقع يستخدم بروتوكول HTTPS

icon

مسجل لدى هيئة الحكومة الرقمية برقم :

20250831619
اقتراحات

قائمة الدراسات السريرية المسجلة على الادوية

عرض 131 - 140 من 518
عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
Multicenter, open-label, study to evaluate safety,tolerability, pharmacokinetics and, pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared with enalapril in pediatric patients from1 month to < 18 years of age with heart failure due to systemic left ventricle systolic dysfunction) Novartis Completed Entresto 3 CLCZ696B2319 KFSH&RC-R , KFSH-D
An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease Novartis Completed ribociclib / letrozole 3b CLEE011A2404 NGHA-R , KFSH&RC-R , KFSH , KAMC , NGHA-J , KFMC
" A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer" Novartis Completed LEE011 (Ribociclib) 3 CLEE011E2301 KKUH , KFSH & RC-R , NGHA-R , NGHA-J
A Retrospective Observational Non-Interventional Study (NIS) to assess Patient Characteristics and Healthcare Resource Use (HCRU) among COVID-19 Patients Receiving Treatment with Nirmatrelvir; Ritonavir (PAXLOVIDTM) in the Kingdom of Saudi Arabia (KSA) Pfizer Ongoing Paxlovid 4 C4671054 King Faisal Specialist Hospital and Research Center (Riyadh) , King Faisal Specialist Hospital and Research Center (Jeddah) , King Abdulaziz Medical City NG (Riyadh) , King Abdulaziz Medical City NG (Riyadh)
Stroke and High-risk TIAs Outcomes with Reduction of Treatment duration in Emergency Rooms. (SHORTER-Study). 3
Non-Interventional Study of the Change in Joint Health in Adult Patients with Haemophilia A after Switching to Prophylaxis with Turoctocog Alfa Pegol (N8-GP) 4
Assessment of Quality of Life in Patients with Relapsing Multiple Sclerosis treated with Cladribine tablets in the Kingdom of Saudi Arabia 4
Randomized, Open-Label, Clinical Trial for Evaluating the Prophylactic Use of Paracetamol for Fasting-induced Headache During the First Week of Ramadan 3
A randomized double-blind placebo-controlled parallel group study assessing the efficacy and safety of dupilumab in patients with Allergic Fungal Rhinosinusitis (AFRS) 3
iOUTRUN: Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients 4